GROWTH@CARE: what changed
What changed
GROWTH@CARE
NACE 86.939, Human health activities
filed annual accounts (NBB)
Net result for the year
€63,820
2024 · €26,099+€37,721
Equity
€182,660
2024 · €119,673+€62,987
Cash
€201,912
2024 · €114,238+€87,675
Balance sheet total
€230,431
2024 · €143,015+€87,416
Largest movements
Assets
- Cash +€87,675
up €87,675 (+76.7%), from €114,238 to €201,912
mainly Net result for the year (+€63,820) and Accrued charges and deferred income (+€20,800)
- Receivables within one year -€4,653
down €4,653 (-16.4%), from €28,307 to €23,654
of which Trade receivables: -€4,655
- Deferred charges and accrued income +€3,238
up €3,238 (+1,472%), from €220 to €3,458
Equity and liabilities
- Reserves +€62,987
up €62,987 (+53.8%), from €117,173 to €180,160
- Accrued charges and deferred income +€20,800
new in 2025: €20,800
- Trade debts +€13,301
up €13,301 (+2,162%), from €615 to €13,917
- Tax, wage and social debts -€10,977
down €10,977 (-65.1%), from €16,864 to €5,887
Income statement
- Gross operating margin +€49,689
up €49,689 (+133%), from €37,478 to €87,167
- Taxes +€11,301
up €11,301 (+109%), from €10,375 to €21,676
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€26,099
Gross operating margin
+€49,689
Depreciation
-€122
Other operating charges
-€46
Financial income
-€202
Financial charges
-€298
Taxes
-€11,301
Result 2025
€63,820
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€89,783
Investment
-€1,278
Financing
-€830
Cash 2024
€114,238
From operations (derived)
+€89,783
Net result for the year
+€63,820
Depreciation
+€122
Receivables within one year
+€4,653
Deferred charges and accrued income
-€3,238
Trade debts
+€13,301
Tax, wage and social debts
-€10,977
Other debts
+€1,301
Accrued charges and deferred income
+€20,800
Investment (derived)
-€1,278
Investment in fixed assets (net)
-€1,278
Financing
-€830
Short-term financial debts
+€3
Contributions, distributions and other
-€833
Cash 2025
€201,912
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €143,015 | €230,431 | +€87,416 | +61.1% |
| Fixed assets | 21/28 | €250 | €1,406 | +€1,156 | +463% |
| Tangible fixed assets | 22/27 | - | €1,156 | +€1,156 | |
| Furniture and vehicles | 24 | - | €1,156 | +€1,156 | |
| Financial fixed assets | 28 | €250 | €250 | = | 0.0% |
| Current assets | 29/58 | €142,765 | €229,024 | +€86,260 | +60.4% |
| Amounts receivable within one year | 40/41 | €28,307 | €23,654 | -€4,653 | -16.4% |
| Trade receivables | 40 | €28,300 | €23,645 | -€4,655 | -16.4% |
| Other amounts receivable | 41 | €7 | €9 | +€2 | +31.5% |
| Cash at bank and in hand | 54/58 | €114,238 | €201,912 | +€87,675 | +76.7% |
| Deferred charges and accrued income | 490/1 | €220 | €3,458 | +€3,238 | +1,472% |
| Total equity and liabilities | 10/49 | €143,015 | €230,431 | +€87,416 | +61.1% |
| Equity | 10/15 | €119,673 | €182,660 | +€62,987 | +52.6% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €117,173 | €180,160 | +€62,987 | +53.8% |
| Distributable reserves | 133 | €117,173 | €180,160 | +€62,987 | +53.8% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €23,341 | €47,770 | +€24,429 | +105% |
| Amounts payable within one year | 42/48 | €23,341 | €26,970 | +€3,629 | +15.5% |
| Financial debts | 43 | €56 | €59 | +€3 | +5.5% |
| Credit institutions | 430/8 | €56 | €59 | +€3 | +5.5% |
| Trade debts | 44 | €615 | €13,917 | +€13,301 | +2,162% |
| Suppliers | 440/4 | €615 | €13,917 | +€13,301 | +2,162% |
| Advances received on contracts in progress | 46 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €16,864 | €5,887 | -€10,977 | -65.1% |
| Taxes | 450/3 | €16,864 | €5,887 | -€10,977 | -65.1% |
| Other amounts payable | 47/48 | €5,807 | €7,108 | +€1,301 | +22.4% |
| Accrued charges and deferred income | 492/3 | - | €20,800 | +€20,800 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €122 | +€122 | |
| Other operating charges | 640/8 | €709 | €755 | +€46 | +6.5% |
| Non-recurring operating charges | 66A | €0 | - | = | |
| Gross operating margin | 9900 | €37,478 | €87,167 | +€49,689 | +133% |
| Operating profit (loss) | 9901 | €36,769 | €86,290 | +€49,521 | +135% |
| Financial income | 75/76B | €202 | €0 | -€202 | -100% |
| Recurring financial income | 75 | €202 | €0 | -€202 | -100% |
| Financial charges | 65/66B | €496 | €794 | +€298 | +59.9% |
| Recurring financial charges | 65 | €496 | €794 | +€298 | +59.9% |
| Profit (loss) for the period before taxes | 9903 | €36,475 | €85,496 | +€49,022 | +134% |
| Income taxes | 67/77 | €10,375 | €21,676 | +€11,301 | +109% |
| Profit (loss) for the period | 9904 | €26,099 | €63,820 | +€37,721 | +145% |
| Profit (loss) for the period to be appropriated | 9905 | €26,099 | €63,820 | +€37,721 | +145% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.